Noelia Cantero-García, Antonio Flores-Burgess, David Ladrón de Guevara-Miranda, Antonia Serrano, Laura García-Durán , Araceli Puigcerver, Kjell Fuxe, José Ángel Narváez, Luis Javier Santín , Zaida Díaz-Cabiale,* and Carmelo Millón*. The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression

Authors are from the Facultad de Medicina de Málaga, Facultad de Psicología de Málaga, Instituto de Investigación Biomédica de Málaga, Unidad de Gestión Clínica de Salud Mental e Instituto de Investigación Biomédica de Málaga, Hospital, Regional Universitario de Málaga,  Department of Neuroscience, Karolinska Institute, 17177 Stockholm, Sweden.

Emails:
noeliacg@uma.es, afburgess@uma.es, david.lgm@uma.es, antonia.serrano@ibima.eu, lauragd_24@uma.es, araceli@uma.es, kjell.Fuxe@ki.se, bueno@uma.es, luis@uma.es, zaida@uma.es, carmelomp@uma.es

Data_GalaninandEscitalopramAUD
Excel table file containing raw data from Figures 2-6 and table 1, divided in sheets, of the related paper. 

Figure 2: SPT. 2A. Sucrose intake (gr/Kg); 2B. Sucrose Preference (%)
Figure 2: Saccharin-self-administration. 2C.Nº ethanol reinforcement (%). 2D,E.Active and inactive lever presses (%)
Figure 3: Ethanol self-administration test. 3B.Nº ethanol reinforcement. 3C,D Active and inactive lever presses.
Figure 4: FST, 4A. Immmobility (s); 4B Swimming (s). 
Figure 4: TST, 4C immobility (s), swimming (s)
Figure 5: VTA C-Fos Immunohistochemistry, 5A. Cfos+TH cell/mm2; 5B. RMTg, LHb, MHb, NAc, CPF, RD C-Fos immunohistochemistry (cells/mm2)
Figure 6: General  regions extracted in principal component analyses. 6A. Factors extracted, 6B.Factor 1 6C. Correlation

Table 1: EPM: entries and time (%); OFT: nº entries and time entries (s)


Groups were coded as:
EPM - Elevated Pluz Maze
ESC - Escitalopram
OFT - Open Field test
GAL(1-15)- Galanin(1-15)
FST - Forced swimming test
SPT - Sucrose Preference Test
TST - Tail suspension test